TriLURON M71389122087901A13
TriLURON M71389122087901A13 (89122-0879-01), a synovial fluid supplementation medium (FDA Class III; FDA product code MOZ, Acid, Hyaluronic, Intraarticular) made by Fidia Farmaceutici, was approved under FDA PMA P180040 on 26 Mar 2019 and listed in FDA GUDID on 4 Nov 2019 (UDI-DI M71389122087901A1); the registry lists it as not in commercial distribution (GUDID) as of 23 Oct 2026.
Active
PMA
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | NumberM71389122087901A1 | Date4 Nov 2019 | StatusListed |
| United States | FDA PMAAPPR | NumberP180040 | Date26 Mar 2019 | StatusActive |
Official records
- FDA PMA database P180040
From the FDA record
- Device description
- TriLURON (sodium hyaluronate) 1 prefilled syringe - 2 mL, 20mg per 2 mL
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied sterile
Across registries
- FDA PMA P180040 decided 26 Mar 2019 Active
- FDA GUDID UDI-DI M71389122087901A1 listed 4 Nov 2019 Listed
Timeline
- Approved FDA PMA P180040
- Listed FDA GUDID M71389122087901A1
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Trade name
- TriLURON
- Generic name
- Synovial fluid supplementation medium
- Model / Ref / Catalog
- M71389122087901A13, 89122-0879-01
- Primary DI / UDI-DI
- M71389122087901A1
- PMA number
- FDA product code
- MOZ
- GMDN term
- Synovial fluid supplementation medium
- Device class
- Class III
- GUDID distribution status
- Not in Commercial Distribution
Similar devices
Other devices filed under FDA product code MOZ (Acid, Hyaluronic, Intraarticular).
- Gel-Syn Acid, Hyaluronic, Intraarticular by Ibsa Institut Biochimique SA
- Monovisc Injectable Intra-Articular Device by Anika Therapeutics, Inc.
- SYNOJOYNT by Mesoblast
- TriVisc by Channel-Markers Medical, LLC
- Synvisc Hylan G-F 20 by Sanofi Genzyme Corp.
- TRILURON by Fidia Farmaceutici S.p.A.
- Supartz by Seikagaku Corp.
- Gel-One by Seikagaku Corp.
- GenVisc 850 by Channel-Markers Medical, LLC
- Orthovisc High Molecular Weight Hyaluronan by Anika Therapeutics, Inc.